Rapid Influenza Diagnostics Market - Top Companies and Manufacturers

Companies Dominating the Rapid Influenza Diagnostic Landscape

Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Hologic, Inc.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Abbott Laboratories
BD
F. Hoffmann-La Roche Ltd
NeuroLogica Corp.
GENERAL ELECTRIC
Quest Diagnostics Incorporated
DiaSorin SpA

Browse Key Market Insights with Data Illustration:

Rapid Influenza Diagnostics Market Size & Share, Forecast Report 2037

In the News

For its quick influenza diagnostic testing device, ID NOW INFLUENZA A & B 2, Abbott got U.S. FDA approval in October 2018. The influenza A and B viruses may be quickly identified and differentiated molecularly with this assay. This product approval helped the business increase its market presence and diversify its offering of influenza diagnostic tests.
The acquisition of Luminex Corporation, a business involved in the development of diagnostic tools for infectious diseases, was announced by DiaSorin SpA in April 2021. The goal of this acquisition was to increase the diagnostic goods available in the United States, including those for the diagnosis of influenza. This tactical choice helped the business grow its clientele and strengthen its position in the market.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of rapid influenza diagnostics is assessed at USD 982.22 million.

The rapid influenza diagnostics market size was valued at USD 921.75 million in 2024 and is anticipated to reach USD 2.56 billion by the end of 2037, expanding at around 8.2% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of influenza and growing research and development will boost the market growth.

North America industry is likely to dominate majority revenue share 33% by 2037, due to presence of leading players in the region.

The major players in the market are of Abbott Laboratories, BD, F. Hoffmann-La Roche Ltd, NeuroLogica Corp., GENERAL ELECTRIC, Quest Diagnostics Incorporated, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.,, and others.

Rapid Influenza Diagnostics Market - Top Companies and Manufacturers

Companies Dominating the Rapid Influenza Diagnostic Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the rapid influenza diagnostics market worth?

Why is the demand for rapid influenza diagnostics growing?

Which region dominated the majority of rapid influenza diagnostics industry share?

Who are the top rapid influenza diagnostics companies?